Evidence map›Paper›PMID 32443835›Full record

ArticlePathogens (Basel, Switzerland)2020

Uncovering the First Atypical DS-1-like G1P[8] Rotavirus Strains That Circulated during Pre-Rotavirus Vaccine Introduction Era in South Africa.

Peter N Mwangi, Milton T Mogotsi, Sebotsana P Rasebotsa, Mapaseka L Seheri, M Jeffrey Mphahlele, Valantine N Ndze, Francis E Dennis, Khuzwayo C Jere, Martin M Nyaga

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Whole-Genome Sequencing of a Colistin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  9. Rotaviruses and Rotavirus Vaccines.Pathogens (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Peter N MwangiNext Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.
Milton T MogotsiNext Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.
Sebotsana P RasebotsaNext Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.
Mapaseka L SeheriDiarrhoeal Pathogens Research Unit, Sefako Makgatho Health Sciences University, Medunsa 0204, Pretoria, South Africa.
M Jeffrey MphahleleSouth African Medical Research Council, 1 Soutpansberg Road, Pretoria 0001, South Africa.
Valantine N NdzeFaculty of Health Sciences, University of Buea, P.O. Box 63, Buea, Cameroon.ORCID 0000-0003-2200-6203
Francis E DennisNoguchi Memorial Institute for Medical Research, University of Ghana, P.O. Box LG581, Legon, Ghana.
Khuzwayo C JereCentre for Global Vaccine Research, Institute of Infection and Global Health, University of Liverpool, Ronald Ross Building, 8 West Derby Street, Liverpool L69 7BE, UK.ORCID 0000-0003-3376-8529
Martin M NyagaNext Generation Sequencing Unit, Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.ORCID 0000-0002-5017-5584
University of the Free State · ZASefako Makgatho Health Sciences University · ZASouth African Medical Research Council · ZAUniversity of Buea · CMUniversity of Ghana · GHUniversity of Liverpool · GB

Funding

Bill and Melinda Gates Foundation OPP1180423_2017National Research Foundation 120814Poliomyelitis Research Foundation PRF 19/16South African Medical Research Council Self Initiated Research (SAMRC-SIR)Wellcome Trust 201945/Z/16/Z
6 · The paper itself

Abstract

Emergence of DS-1-like G1P[8] group A rotavirus (RVA) strains during post-rotavirus vaccination period has recently been reported in several countries. This study demonstrates, for the first time, rare atypical DS-1-like G1P[8] RVA strains that circulated in 2008 during pre-vaccine era in South Africa. Rotavirus positive samples were subjected to whole-genome sequencing. Two G1P[8] strains (RVA/Human-wt/ZAF/UFS-NGS-MRC-DPRU1971/2008/G1P[8] and RVA/Human-wt/ZAF/UFS-NGS-MRC-DPRU1973/2008/G1P[8]) possessed a DS-1-like genome constellation background (I2-R2-C2-M2-A2-N2-T2-E2-H2). The outer VP4 and VP7 capsid genes of the two South African G1P[8] strains had the highest nucleotide (amino acid) nt (aa) identities of 99.6-99.9% (99.1-100%) with the VP4 and the VP7 genes of a locally circulating South African strain, RVA/Human-wt/ZAF/MRC-DPRU1039/2008/G1P[8]. All the internal backbone genes (VP1-VP3, VP6, and NSP1-NSP5) had the highest nt (aa) identities with cognate internal genes of another locally circulating South African strain, RVA/Human-wt/ZAF/MRC-DPRU2344/2008/G2P[6]. The two study strains emerged through reassortment mechanism involving locally circulating South African strains, as they were distinctly unrelated to other reported atypical G1P[8] strains. The identification of these G1P[8] double-gene reassortants during the pre-vaccination period strongly supports natural RVA evolutionary mechanisms of the RVA genome. There is a need to maintain long-term whole-genome surveillance to monitor such atypical strains.

Indexed as

atypical strainsgenome constellationreassortmentrotaviruswhole-genome characterization

Identifiers

PMID32443835
PMCPMC7281366
OpenAlexW3026337500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.